Follow
Laura Indolfi
Laura Indolfi
CEO and Founder, PanTher Therapeutics
Verified email at mit.edu
Title
Cited by
Cited by
Year
Microsphere-integrated collagen scaffolds for tissue engineering: effect of microsphere formulation and scaffold properties on protein release kinetics
F Ungaro, M Biondi, I d'Angelo, L Indolfi, F Quaglia, PA Netti, ...
Journal of controlled Release 113 (2), 128-136, 2006
1052006
Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance
AB Baker, WJ Gibson, VB Kolachalama, M Golomb, L Indolfi, C Spruell, ...
Journal of the American College of Cardiology 59 (17), 1551-1560, 2012
652012
The role of scaffold microarchitecture in engineering endothelial cell immunomodulation
L Indolfi, AB Baker, ER Edelman
Biomaterials 33 (29), 7019-7027, 2012
522012
A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma
L Indolfi, M Ligorio, DT Ting, K Xega, AR Tzafriri, F Bersani, N Aceto, ...
Biomaterials 93, 71-82, 2016
412016
Coating process and early stage adhesion evaluation of poly (2-hydroxy-ethyl-methacrylate) hydrogel coating of 316L steel surface for stent applications
L Indolfi, F Causa, PA Netti
Journal of Materials Science: Materials in Medicine 20 (7), 1541-1551, 2009
392009
Tubular bridges for bronchial epithelial cell migration and communication
BG Zani, L Indolfi, ER Edelman
PloS one 5 (1), e8930, 2010
352010
Bioactivated collagen-based scaffolds embedding protein-releasing biodegradable microspheres: tuning of protein release kinetics
M Biondi, L Indolfi, F Ungaro, F Quaglia, MI La Rotonda, PA Netti
Journal of Materials Science: Materials in Medicine 20, 2117-2128, 2009
292009
Bioactivated polymer scaffolds for tissue engineering
F Ungaro, M Biondi, L Indolfi, G De Rosa, MI La Rotonda, F Quaglia, ...
Topics in tissue engineering 2, 1-39, 2005
262005
Microsphere‐integrated drug‐eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents
L Indolfi, F Causa, C Giovino, F Ungaro, F Quaglia, PA Netti
Journal of Biomedical Materials Research Part A 97 (2), 201-211, 2011
252011
Local drug delivery devices and methods for treating cancer
L Indolfi, ER Edelman, RS Langer, JW Clark, DT Ting, CRA Ferrone, ...
US Patent 9,301,926, 2016
232016
Matrix-embedded endothelial cells are protected from the uremic milieu
VC Chitalia, S Murikipudi, L Indolfi, L Rabadi, R Valdez, JW Franses, ...
Nephrology Dialysis Transplantation 26 (12), 3858-3865, 2011
192011
A novel drug-eluting platform for localized treatment of pancreatic cancer
M Ligorio, L Indolfi, DT Ting, K Xega, N Aceto, F Bersani, CR Ferrone, ...
Cancer Research 74 (19_Supplement), 4584-4584, 2014
22014
Harnessing cell: materials interactions to develop innovative strategy for the recruitment of progenitor cells
L Indolfi, C Iaconetti, A Monteforte, A Dunn, A Baker, C Indolfi, E Edelman
Society for Biomaterials. Annual Meeting, 2014
22014
Novel targeted and sustained drug delivery therapy for localized pancreatic cancer: Validation in porcine models and minimally invasive surgical feasibility in human cadavers.
M Lashof-Sullivan, MP Kim, CWD Tzeng, L Indolfi
Journal of Clinical Oncology 38 (15_suppl), e16747-e16747, 2020
12020
Abstract B26: Targeted and sustained drug delivery therapy for localized pancreatic cancer: In vivo validation in porcine models
M Lashof-Sullivan, AL McSweeney, DT Ting, MP Kim, CWD Tzeng, ...
Cancer Research 79 (24_Supplement), B26-B26, 2019
12019
Local drug delivery devices and methods for treating cancer
L Indolfi, ER Edelman, RS Langer, JW Clark, CRA FERRONE, M LIGORIO
12019
Development of a novel implantable drug-eluting product for the local treatment of pancreatic adenocarcinoma
M Lashof-Sullivan, LS Sloan, MP Kim, L Indolfi, CWD Tzeng
Cancer Research 84 (6_Supplement), 2393-2393, 2024
2024
Tissue penetrating and biodegradable drug delivery devices and methods of use thereof
L Indolfi, M Lashof-sullivan, D Wildman, CDL Johnson
US Patent App. 18/356,925, 2024
2024
Implantable and biodegradable drug delivery devices and methods of use thereof
L Indolfi, M Lashof-sullivan
US Patent App. 18/056,315, 2023
2023
Phase I study of PTM-101 as neoadjuvant therapy for borderline resectable or locally advanced pancreatic ductal adenocarcinoma: A trial in progress.
C Pilgrim, M Smith, J Ban, S Ellis, JR Zalcberg, B Markman, ...
Journal of Clinical Oncology 41 (4_suppl), TPS775-TPS775, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20